4//SEC Filing
Trieu Vuong 4
Accession 0001493152-21-022220
CIK 0000908259other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:00 PM ET
Size
5.5 KB
Accession
0001493152-21-022220
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Award
Stock Options
2021-09-03+225,000→ 225,000 totalExercise: $0.14Exp: 2031-09-03→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 1/5th on September 30, 2021; (ii) 1/5th on December 31, 2021; (iii) 1/5th on March 31, 2022; (iv) 1/5th on June 30, 2022; and (v) 1/5th on September 30, 2022.
Documents
Issuer
Oncotelic Therapeutics, Inc.
CIK 0000908259
Entity typeother
Related Parties
1- filerCIK 0001587074
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:00 PM ET
- Size
- 5.5 KB